Medelinked is the First Application to Feature in BioClinica's App xChange

MedelinkedMedelinked, the online health platform that empowers healthcare engagement and management, has announced that it will be the first application featured in the BioClinica®, eHealth App xChange™, an alliance channel for disruptive technology innovation across life sciences and healthcare.

Medelinked allows individuals to use mobile technology and the cloud to increase the effectiveness of health care by enabling them to securely build their health profile online and to connect and share with their network of trusted health partners.

Pennsylvania -based BioClinica, a global specialty clinical trials technology and services provider that serves more than 400 pharmaceutical, biotechnology, and device organizations, recently launched the eHealth App xChange. It provides healthcare payers, providers, researchers, regulators and patients with access to transformative applications integrated with and delivered through BioClinica's eHealth Cloud™.

Leading innovation in regulated clinical trials
BioClinica eClinical President, Mukhtar Ahmed says: "Our App xChange is an incubator and growth engine for niche technology providers and individual app developers, so we welcome Medelinked as the first in a series of new partners as BioClinica continues to lead industry innovation within the regulated clinical trial space."

Ahmed continues: "Medelinked’s presence in the App xChange will enable research communities to ensure unique levels of patient and consumer engagement so accelerating pre- and post-approval research while creating efficiency and quality benefits."

Driving the global shift in how patients and the healthcare industry connect
Ian Gallifant, Medelinked founder and CEO, says: "With this latest development, Medelinked is further driving the global shift in how patients and the healthcare industry connect from early clinical research and trials right through to day-to-day health management. The fact that BioClinica has chosen Medelinked to be the first to feature on its new strategic and disruptive platform is a profound endorsement of the quality and effectiveness of Medelinked’s technology."

About Medelinked
Medelinked was founded in order to allow individuals to use mobile technology and the cloud to increase the effectiveness of health care by enabling them to securely build their health profile online and to connect and share with their network of trusted health partners.

Managing all their health data in one place helps individuals securely track and monitor improvements easier and quicker and share vital data with their healthcare providers (doctor, consultant, insurer, pharma) to ensure they have access to their latest health data. This enables them to provide the best possible care and it keeps the individual in control of their own health. The Medelinked Health Cloud and API is also allowing developers to create series of new applications that deliver real health benefits to the end user.

Medelinked was founded in 2005 and is based in Oxfordshire, UK.

About BioClinica, Inc.
BioClinica is a specialty clinical trials services provider that improves the development of new medical therapies by delivering expertise and technologies that enhance clinical research data and analytics, worldwide. The company offers industry-leading medical imaging services, enterprise eClinical technologies, patient recruitment and retention, clinical research centers and cardiovascular safety solutions that bring quality and efficiency to every phase of clinical development.

BioClinica's experience spans three decades and includes thousands of studies in all therapeutic areas. The company serves more than 400 pharmaceutical, biotechnology, and device organizations - including all of the top 20 - through a network of offices in the U.S., Europe and Asia.

Most Popular Now

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...